This webinar will present the history, science, material culture, and social impact of cannabis and stimulant abuse on adolescents, adults, and their use as patented medications to treat mental illnesses.
Benjamin Roy, MD is President of the Black Psychiatrists of America. He received his medical degree from Howard University College of Medicine and served his internship in internal medicine at Harlem Hospital and a psychiatry residency at St. Vincent’s Hospital, both in New York, NY. He then completed a clinical fellowship in neuropharmacology at the National Institute of Mental Health and in neuroimmunology at the National Institute of Neurological, Communicative Disorders and Stroke, NIH, both in Bethesda, MD. He is a diplomate of the American Board of Psychiatry and Neurology and Fellow of the American Psychiatric Association. Dr. Roy discovered human antibodies for endorphins and the opiate receptor in patients with psychiatric disorders and holds two US patents on methods of detecting certain antibodies in human body fluids. He has participated in numerous phase 2-4 clinical trials in neuropharmacology and neuroimmunology. He exposed the purpose of the Tuskegee Syphilis Experiment to develop syphilis diagnostic tests that were patented and commercialized.
- Discuss the history of cannabis and stimulant abuse
- Identify Loud, Dojo, Gas, Lean, Purple Drank, Syrup, Sizzurp, Barre, and Texas Tea abuse
- Identify the impact of Cannabis and stimulant abuse on cognitive function, lasting mood and psychotic disorders, mortality, and morbidity
- Disseminate scientific and clinical information on Lean and Loud abuse to the public health community
- Learn potential susceptibility of Cannabis, Lean abuse to COVID-19
- Construct a network that provides support, exchanges information, and generates new knowledge to support and improve treatment of Lean, Purple Drank, opiate, and Loud abuse
Who Should Attend?
Mental health professionals; mental health advocates; mental health caretakers
Certificates of attendance will be available to viewers of 50% (30 minutes) or more of the live webinar (via email within 30 business days post-event). CEUs are not offered for this session. Webinar slide presentations and recordings will be posted to the website.